The integration of fluorine into medicinal compounds has become a widely used strategy to improve the biochemical and therapeutic properties of drugs. Inclusion of −CF 2 H and −OCF 3 fluoroalkyl groups has garnered attention due to their bioisosteric properties, enhanced lipophilicity, and potential hydrogen-bonding capability in bioactive substances. In this study, we prepared a series of stable Cu[CF(OCF 3 )-(CF 2 H)]L n complexes by insertion of commercially available perfluoro-(methyl vinyl ether), CF 2 �CF(OCF 3 ), into Cu−H bonds derived from Stryker's reagent, [CuH(PPh 3 )] 6 , using ancillary ligands L. Notably, certain of these complexes effectively transfer the fluoroalkyl group to aroyl chlorides. Through reaction optimization and computational analysis, we identified dimethylsulfoxide as a pivotal coligand, playing a distinctive role in enabling the fluoroalkylation of a range of aroyl chlorides and aryl iodides. The latter also benefits from addition of CuBr to abstract PPh 3 , generating solvent-stabilized Cu[CF(OCF 3 )(CF 2 H)]. These methodologies allow for the introduction of geminal −OCF 3 and −CF 2 H groups in a single transformation.